Penumbra Balance Sheet
NYSE: PENHealth CareMedical/Dental InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Penumbra financial position
At the end of fiscal 2025, Penumbra reported total assets of $1.83 billion, up 19.1% from a year earlier against total liabilities of $398.9 million. Shareholders' equity stood at $1.43 billion, or 78.2% of assets. The company held $186.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 6.64, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Penumbra balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 186.90M | 324.40M | 167.49M | 69.86M | 59.38M | 69.67M | 72.78M | 67.85M | 50.64M | 13.24M |
| Short-Term Investments | 357.92M | 15.73M | 121.70M | 118.17M | 195.50M | 195.16M | 116.61M | 133.04M | 163.95M | 115.52M |
| Receivables | 190.02M | 167.67M | 201.77M | 203.38M | 133.94M | 114.61M | 105.90M | 81.90M | 58.01M | 43.34M |
| Inventory | 431.55M | 406.74M | 388.02M | 334.01M | 263.50M | 219.53M | 152.99M | 115.74M | 94.90M | 73.01M |
| Total Current Assets | 1.22B | 951.13M | 915.40M | 755.70M | 681.47M | 617.70M | 463.13M | 410.73M | 382.23M | 263.83M |
| Property, Plant & Equipment | 117.44M | 62.64M | 72.69M | 65.02M | 58.86M | 48.17M | 51.81M | 35.41M | 30.90M | 21.46M |
| Goodwill | 166.75M | 165.83M | 166.27M | 166.05M | 166.39M | 8.37M | 7.66M | 7.81M | 8.18M | 0 |
| Intangible Assets | 6.19M | 6.51M | 71.06M | 81.16M | 90.62M | 10.64M | 25.41M | 27.25M | 23.78M | 0 |
| Long-Term Investments | — | — | — | — | — | — | — | 0 | 3.87M | 0 |
| Total Assets | 1.83B | 1.53B | 1.56B | 1.37B | 1.24B | 822.98M | 665.90M | 515.01M | 476.67M | 308.25M |
| Accounts Payable | 34.74M | 31.33M | 27.16M | 26.68M | 13.42M | 14.11M | 15.11M | 8.18M | 6.76M | 4.11M |
| Total Current Liabilities | 183.13M | 158.34M | 151.14M | 144.93M | 123.20M | 105.93M | 91.05M | 66.06M | 51.58M | 35.80M |
| Total Liabilities | 398.92M | 382.25M | 377.36M | 372.03M | 290.32M | 185.19M | 180.29M | 92.59M | 76.26M | 41.71M |
| Shareholders' Equity | 1.43B | 1.15B | 1.18B | 998.86M | 953.93M | 641.50M | 485.89M | 422.24M | 400.41M | 266.55M |
| Retained Earnings | 237.69M | 60.00M | 134.86M | 43.90M | 45.91M | 40.62M | 57.52M | 9.06M | 2.00M | -2.66M |
| Net Cash (Debt) | 544.82M | 340.13M | 289.19M | 188.03M | 254.88M | 264.83M | 189.39M | 200.89M | 214.59M | 128.75M |
| Shares Outstanding | 39.23M | 38.49M | 38.68M | 38.11M | 37.58M | 36.41M | 35.00M | 34.44M | 33.69M | 31.11M |
This table shows 10 annual periods of Penumbra's balance sheet, from FY 2025 back to FY 2016, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow PEN's reporting calendar. What is a balance sheet?